To evaluate the heart and the Tc-99m-sestamibi biodistribution after statin pretreatment in a rat model of abdominal sepsis.
. It has been also been established that statins can increase the expression of nitric oxide (NO) 7 .
In sepsis induced cardiac dysfunction, a protective role for statins has been suggested. Using a circulatory shock model induced by lipopolysaccharide (LPS) in guinea pigs, Giuoti-Paiva et al. 8 evaluated the production of NO and the cardiovascular response to the infusion of phenylephrine in simvastatin treated or non-treated groups. NO levels increased significantly two hours after the injection of LPS compared to the control group. In the group pre-treated with simvastatin the NO levels were significantly reduced. LPS injection produced prolonged hypotension in the experimental group; pretreatment with simvastatin did not prevent this hypotensive effect, but the response to phenylephrine was restored in the statin treated group.
Another factor responsible for septic cardiac dysfunction is the poor distribution of regional blood flow induced by sepsis.
Poor blood flow distribution can contribute to myocardial dysfunction, generating areas of ischemia. It is assumed that statins also have vasoprotective effects. In a study by Liuba et al. Tc-sestamibi is a radiopharmaceutical that is widely used for myocardial perfusion imaging. The kinetics of this radiopharmaceutical in the myocardium and its biodistribution has been reported in several experimental models 10, 11 . In the presence of irreversible myocardial injury, mitochondrial membranes are depolarized by changing the uptake of Tc-sestamibi is dependent on the myocardial tissue viability and regional blood flow 13 .
Assuming that cardiac dysfunction can be caused or aggravated by sepsis, and that the inhibition of inflammation is one of many pleiotropic effects of statins, we tested the following hypothesis: pretreatment with simvastatin have a protection effect on the heart, and can possibly have an impact on the cardiac uptake and biodistribution of 99m Tc-sestamibi using an experimental model of abdominal sepsis in rats. 
Methods

Twenty
Sepsis induction
Animals were fasted 12h before the experiment and anesthetized with intramuscular injection of 0.1 mL/100g weight, of a solution prepared with 1.0 mL of ketamine (50mg/mL) and 1.0 mL of xilazine (20mg/mL). They breathed spontaneously throughout the procedures. After shaving, the abdominal skin was disinfected with 70% alcohol. All procedures were performed under sterile conditions.
A 3 cm midline laparotomy was performed and cecal ligation and puncture (CLP) was performed. The cecum was exposed, ligated with After obtaining the tissue biodistribution measurements, the fresh hearts were cut and washed in running water to enable rapid and uniform action of the fixative solution. Then the samples were fixed in 10% buffered formalin for 48 hours and processed for 18 hours in an automatic tissue processor, using Leica equipment TP 1020, German.
Prior to embedding in paraffin, the left ventricles of fixed hearts were cut with punch (6 mm diameter), for standardization of samples.
Histological sections were obtained with microtome Leica RM 2125 RTS, 03 microns thick. The fixed specimens were stained with hematoxylin/eosin for morphological analysis by optical microscopy, using the CX41 microscope (Olympus, Tokyo, Japan). Sections were examined in high magnification power fields (x400) to determine the presence of adherent and infiltrating neutrophils, eosinophils, basophils, monocytes, lymphocytes and platelets. The total number of cells was analyzed in six fields for each heart expressed in cells per square millimeter. The quantitative analysis was performed using a video-assisted software (Image ProPlus 6.0, Media Cyber).
Data analysis
All data were presented as mean±standard deviation and compared by ANOVA and Tukey test. The difference between the means was considered statistically significant when p <0.05.
Results
All animals survived the experiments. Contraction necrosis or interstitial fibrosis was not seen in any of the evaluated hearts. Interstitial edema, mononuclear infiltrate, myocytolysis and tissue hemorrhage were found, but no differences were detected when comparing sepsis and sham groups, with and without treatment with simvastatin.
The average time for resection of organs for weighing on a precision scale and measurements of the 99m Tc-sestamibi activities was 10 minutes per animal. Table 1 show the percentage of the injected activity per gram of tissue (% ID/g) detected in the heart, lung, kidney and liver, in each group.
The highest %ID of 99m Tc-sestamibi per gram of tissue was detected in the heart and kidney both in sham and in the sepsis groups ( Table 1 ). The lowest %ID of 99m Tc-sestamibi per gram of tissue was detected in the lungs in all groups (Table 1 ).
There were no significant differences in the %ID/g (Table 1) . The %ID/g of the liver and the kidney was significantly higher in the sepsis groups, when compared with the sham groups ( Table 1) . The %ID/g in the heart and lung was lower in the sepsis group treated with saline when compared to sham, however with no significant difference ( Table 1) . The %ID/g of the heart was significantly higher in the sepsis group pretreated with simvastatin than in the sepsis group treated with saline. The myocardium activity was also significantly higher than in sham groups treated with simvastatin and with saline. There was also a significant %ID/g of tissue in the lung, kidney and liver in sepsis groups treated with simvastatin, when compared with the control groups, and when compared to the sepsis group treated with saline (Table 1) . 
Organs
Discussion
Recently, our group showed that simvastatin had significant anti-inflammatory effect in rats with abdominal sepsis, using the CLP model. The results showed that TNF-α, IL-1β and IL-6 values in septic group previously treated with simvastatin were significantly lower than in the untreated sepsis group. The same occurred in total leukocytes and neutrophils 14 . In another study, our group showed that simvastatin also had important anti-inflammatory action in the abdominal sepsis in diabetic rats.
Simvastatin reduced mortality in diabetic rats. Serum levels of TNF-α, IL-1β, IL-6, C-reactive protein, procalcitonin, leukocytes, and neutrophils were significantly lower in diabetic and nondiabetic rats with sepsis treated with simvastatin, than in the group treated with saline 15 . In this study, cardiac and systemic effects of simvastatin pretreatment were analyzed in septic rats, using Some studies have demonstrated that during inflammation, the expression of several carriers is modified in rodents. Previous studies have described downregulation of the expression of mRNA mdr1a, mdr1b, MRP2 and SPGP as well as lower activity of liver P-glycoprotein 17 . It has been stated that the release of proinflammatory cytokines, including TNF-α, IL-1β and IL-6 during the inflammatory response is primarily involved in mediating the downregulation 18 .
Overall, the results of our study showed that CLPinduced abdominal sepsis was associated with increased retention of 99m
Tc-sestamibi in the heart and in the liver, kidney and lung samples, especially in sepsis group pretreated with simvastatin.
Wang et al. 19 showed similar results evaluating the activity of P-glycoprotein through the biodistribution of Previous studies have demonstrated that P-glycoprotein and mdr1 mRNA are expressed in the endothelium of arterioles and capillaries of the heart 22 . Wang et al. 19 detected mdr1a mRNA in heart, but at lower levels than those in the liver and kidney.
However, mdr1a levels were significantly depressed in the heart of LPS-treated mice, but this decrease caused only slight changes in the cardiac biodistribution of 
Conclusions
Statin treatment altered the biodistribution of Tc-99m-sestamibi with increased cardiac and solid organ activity in rats with abdominal sepsis, while no impact on controls. Increased myocardial tracer activity may be a result of a possible protection effect due to increased tissue perfusion mediated by statins.
